Personalised medicine in asthma: time for action

Kian Fan Chung

Source: Eur Respir Rev, 26 (145) 170064; 10.1183/16000617.0064-2017
Journal Issue: September
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kian Fan Chung. Personalised medicine in asthma: time for action. Eur Respir Rev, 26 (145) 170064; 10.1183/16000617.0064-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Personalised medicine in exacerbations of COPD: the beginnings
Source: Eur Respir J 2012; 40: 1318-1319
Year: 2012


Personalised medicine in asthma: from curative to preventive medicine
Source: Eur Respir Rev 2017; 26: 160010
Year: 2017



Personalised medicine in paediatric asthma, including from the patient's perspective
Source: International Congress 2016 – PG8 Paediatric asthma
Year: 2016


Evaluation of the use of e-learning in training management of asthma and COPD in general medicine.
Source: International Congress 2017 – Medical education, web and internet
Year: 2017

Asthma susceptibility: from pathophysiology to personalised medicine
Source: International Congress 2015 – ME4 Asthma susceptibility
Year: 2015




Personalised medicine: are we ready?
Source: Eur Respir Rev, 26 (145) 170088; 10.1183/16000617.0088-2017
Year: 2017



Personalised medicine: how ready are we for this?
Source: Annual Congress 2013 –Ceremony for the ERS Maurizio Vignola Award for Best Publication on Innovation in Pneumology (financially supported by Chiesi Foundation) followed by Hot Topic: Towards delivering personalised or precision medicine in respiratory healthcare
Year: 2013


Biomarkers and personalised medicine for asthma
Source: Eur Respir J, 53 (1) 1802094; 10.1183/13993003.02094-2018
Year: 2019



Personalised targeted medicine
Source: Research Seminar 2015 - Personalising respiratory care in Europe
Year: 2015

Personalised medicine: a step forward to better care?
Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research
Year: 2013



Personalized medicine in the evaluation of sleep breathing disorders - The contribution of stomatology
Source: Sleep and Breathing Conference 2021
Year: 2021

What is new in paediatric asthma?
Source: Annual Congress 2006 - Paediatric year in review
Year: 2006


Challenges for exercise therapy for severe asthma: A healthcare professional perspective
Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases
Year: 2016

Implementation of personalized treatment of asthma by improved phenotyping: Critical review of knowledge gaps and unmet research needs by the European asthma research & innovation partnership (EARIP) expert panel
Source: International Congress 2016 – Phenotyping asthma
Year: 2016


The use and abuse of steroids in asthma action plans
Source: International Congress 2015 – Any news from the asthma field?
Year: 2015



E-learning course on COPD prevention for Russian GP: what do the doctors say?
Source: Annual Congress 2007 - Smoking and the lung
Year: 2007


Personalised medicine through biological subphenotyping of ARDS
Source: Virtual Congress 2021 – Acute respiratory distress syndrome phenotypes: implications for diagnosis and treatment
Year: 2021

A personalised medicine approach to ICS use in COPD
Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care
Year: 2019

Asthma education: an essential component in asthma management
Source: Eur Respir J 2015; 46: 1262-1264
Year: 2015